Pharmacoeconomic aspects of COVID-19 treatment
The article provides an overview of global trends in various treatment approaches for COVID-19 in terms of pharmacoeconomic effectiveness. Different strategies for managing patients with the new coronavirus infection, separate groups of drugs are considered. The current clinical trials for COVID-19,...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2021-10-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849696899002531840 |
|---|---|
| author | I. V. Rogova E. A. Zhidkova I. A. Popova A. V. Zaborovskiy K. G. Gurevich |
| author_facet | I. V. Rogova E. A. Zhidkova I. A. Popova A. V. Zaborovskiy K. G. Gurevich |
| author_sort | I. V. Rogova |
| collection | DOAJ |
| description | The article provides an overview of global trends in various treatment approaches for COVID-19 in terms of pharmacoeconomic effectiveness. Different strategies for managing patients with the new coronavirus infection, separate groups of drugs are considered. The current clinical trials for COVID-19, the main directions, problems and challenges facing the healthcare system are discussed in detail. The aspects of the economic efficiency of various measures to prevent the spread of COVID-19 are presented. A thorough study of the pharmacoeconomic features of the new coronavirus infection will allow to develop effective standards for planning the process of supply for medical organizations in the pandemic. |
| format | Article |
| id | doaj-art-7bdcff65e4bb4dccb00832a9c0e040fd |
| institution | DOAJ |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2021-10-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-7bdcff65e4bb4dccb00832a9c0e040fd2025-08-20T03:19:20ZrusIRBIS LLCФармакоэкономика2070-49092070-49332021-10-0114335736410.17749/2070-4909/farmakoekonomika.2021.086358Pharmacoeconomic aspects of COVID-19 treatmentI. V. Rogova0E. A. Zhidkova1I. A. Popova2A. V. Zaborovskiy3K. G. Gurevich4Yevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and Dentistry; Central Directorate of Healthcare – branch of Russian Railways JSCYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryThe article provides an overview of global trends in various treatment approaches for COVID-19 in terms of pharmacoeconomic effectiveness. Different strategies for managing patients with the new coronavirus infection, separate groups of drugs are considered. The current clinical trials for COVID-19, the main directions, problems and challenges facing the healthcare system are discussed in detail. The aspects of the economic efficiency of various measures to prevent the spread of COVID-19 are presented. A thorough study of the pharmacoeconomic features of the new coronavirus infection will allow to develop effective standards for planning the process of supply for medical organizations in the pandemic.https://www.pharmacoeconomics.ru/jour/article/view/550pharmacoeconomical efficiencypandemiccovid-19healthcare |
| spellingShingle | I. V. Rogova E. A. Zhidkova I. A. Popova A. V. Zaborovskiy K. G. Gurevich Pharmacoeconomic aspects of COVID-19 treatment Фармакоэкономика pharmacoeconomical efficiency pandemic covid-19 healthcare |
| title | Pharmacoeconomic aspects of COVID-19 treatment |
| title_full | Pharmacoeconomic aspects of COVID-19 treatment |
| title_fullStr | Pharmacoeconomic aspects of COVID-19 treatment |
| title_full_unstemmed | Pharmacoeconomic aspects of COVID-19 treatment |
| title_short | Pharmacoeconomic aspects of COVID-19 treatment |
| title_sort | pharmacoeconomic aspects of covid 19 treatment |
| topic | pharmacoeconomical efficiency pandemic covid-19 healthcare |
| url | https://www.pharmacoeconomics.ru/jour/article/view/550 |
| work_keys_str_mv | AT ivrogova pharmacoeconomicaspectsofcovid19treatment AT eazhidkova pharmacoeconomicaspectsofcovid19treatment AT iapopova pharmacoeconomicaspectsofcovid19treatment AT avzaborovskiy pharmacoeconomicaspectsofcovid19treatment AT kggurevich pharmacoeconomicaspectsofcovid19treatment |